Facebook
Twitter
Telegram
Report an ErrorCidara Therapeutics Financial Statements 2011-2024 | CDTX
Annual Financial Statements Cidara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
44.6 M | 120 M | 86.2 M | 86.4 M | 99.5 M | 71.7 M | 131 M | 138 M | 116 M | - | - | - | - |
Shares |
87.4 M | 69.9 M | 67.9 M | 43.2 M | 29.1 M | 25.1 M | 17.5 M | 14.5 M | 9.92 M | - | - | - | - |
Historical Prices |
0.51 | 1.72 | 1.27 | 2 | 3.84 | 2.35 | 6.8 | 10.4 | 17.2 | - | - | - | - |
Net Income |
-22.9 M | -33.6 M | -42.5 M | -72.1 M | -41.1 M | -59 M | -55.7 M | -48.2 M | -32.2 M | -11.9 M | -1.34 M | - | - |
Revenue |
63.9 M | 64.4 M | - | - | 20.9 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-24.5 M | -33.5 M | -42.3 M | -71.8 M | -41.7 M | -63.3 M | -55.7 M | -48.4 M | -32.3 M | -11.6 M | -1.08 M | - | - |
Interest Expense |
2 M | 191 K | -212 K | -262 K | 632 K | 4.27 M | -7 K | 271 K | 120 K | -271 K | - | - | - |
EBITDA |
-24.4 M | -33.4 M | -42.1 M | -71.6 M | -41.4 M | -62.8 M | -55.1 M | -47.7 M | -31.9 M | -8.23 M | -1.08 M | - | - |
Operating Expenses |
88.4 M | 98 M | 91.8 M | 83.9 M | 62.6 M | 63.3 M | 55.7 M | 48.4 M | 32.3 M | - | - | - | - |
General and Administrative Expenses |
18.3 M | 20.5 M | 18.7 M | 15.9 M | 16.2 M | 14.1 M | 12.9 M | 12.7 M | 8.84 M | 3.31 M | 272 K | - | - |
All numbers in USD currency
Quarterly Income Statement Cidara Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.54 M | 4.53 M | 90.3 M | 90.1 M | 3.93 M | 72.5 M | 70.2 M | 69.1 M | 68.1 M | 67.9 M | 49.5 M | 48.7 M | 47 M | 44.9 M | 43.2 M | 41 M | 37.9 M | 33.3 M | 34 M | 28.6 M | 28.5 M | 27.8 M | 27.7 M | 23.6 M | 20.9 M | 19.5 M | 16.9 M | 16.8 M | 16.8 M | 16.4 M | 13.9 M | 13.9 M | 13.8 M | 13.7 M | 13.7 M | 11 M | 1.14 M | 1.13 M | 1.11 M | 638 K | 390 K | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-10.3 M | - | -8.17 M | -12.4 M | 3.01 M | - | 15 M | -13.1 M | -18.3 M | - | -18.1 M | 10.7 M | -18.3 M | - | -17.6 M | -18.3 M | -14.5 M | -14 M | 3.04 M | -13.5 M | -16.6 M | -12.3 M | -13.6 M | -16.3 M | -16.7 M | -13.4 M | -12.3 M | -16.6 M | -13.4 M | -14.4 M | -12.2 M | -11.8 M | -9.79 M | -9.87 M | -9.17 M | -6.41 M | -6.74 M | -4.65 M | -3.32 M | -3.22 M | -707 K | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
8.46 M | - | 12.7 M | - | 26.1 M | - | 40.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.7 M | - | -8.56 M | -12.8 M | 2.78 M | - | 14.9 M | -13.1 M | -18.3 M | - | -18 M | 10.8 M | -18.2 M | - | -17.5 M | -18.2 M | -14.6 M | - | 3.03 M | -14.3 M | -16.4 M | - | -14.7 M | -15.2 M | -16.8 M | - | -12.2 M | -16.6 M | -13.4 M | - | -12.3 M | -11.9 M | -9.88 M | - | -9.21 M | -6.45 M | -6.73 M | - | -3.32 M | -3.1 M | -559 K | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
365 K | - | 613 K | 623 K | 232 K | - | 55 K | -6 K | -20 K | - | -47 K | -62 K | -70 K | - | - | - | - | - | - | 721 K | -157 K | - | -4 K | -1.15 M | 61 K | - | -8 K | -30 K | - | - | 109 K | 107 K | 96 K | - | 33 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-10.7 M | - | - | - | 2.81 M | - | 15 M | -13 M | -18.2 M | - | -17.9 M | 10.9 M | -18.2 M | - | -17.3 M | -18.1 M | -14.5 M | - | 3.28 M | -14.1 M | -16.3 M | - | -14.3 M | -14.9 M | -16.7 M | - | -11.7 M | -16.2 M | -13.2 M | - | -11.8 M | -11.5 M | -9.71 M | - | -8.92 M | -6.26 M | -6.64 M | - | -3.23 M | -3.08 M | -559 K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
19.2 M | - | 21.3 M | 20.4 M | 23.3 M | - | 25.8 M | 19.3 M | 25.4 M | - | 25.1 M | 22.1 M | 20.6 M | - | 19.9 M | 21.6 M | 17.1 M | 15.9 M | 16.1 M | 14.3 M | 16.4 M | 16.6 M | 14.7 M | 15.2 M | 16.8 M | 13.5 M | 12.2 M | 16.6 M | 13.4 M | 14.4 M | 12.3 M | 11.9 M | 9.88 M | 9.93 M | 9.21 M | 6.45 M | 6.73 M | 4.65 M | 3.32 M | 3.1 M | 559 K | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6 M | - | 3.56 M | 3.31 M | 4.46 M | - | 5.78 M | 4.07 M | 5.2 M | - | 4.61 M | 4.37 M | 4.78 M | - | 3.69 M | 3.97 M | 4.1 M | - | 4.57 M | 3.52 M | 3.74 M | - | 3.45 M | 3.53 M | 3.61 M | - | 3.09 M | 3.42 M | 3.16 M | - | 3.61 M | 3.39 M | 2.7 M | - | 2.44 M | 2.24 M | 1.8 M | - | 1.33 M | 522 K | 281 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency